Microsoft heads into its Q4 2026 earnings release tonight with the stock recovered to $393.35, but a stark contrast has opened up with close peers that makes the bounce look modest at best.
The peer divergence is the sharpest signal this week. SAP has rallied 16.7% in the past seven days. GWRE is up 11.8%. TEAM has added 10.4%. NOW and CRM each gained more than 6%. Microsoft's -1.1% on the week stands out against that backdrop — the enterprise software complex is moving, and MSFT is not moving with it. The stock recovered 1.1% on Tuesday, but it closed the prior Friday at $381.70, meaning the weekly number still shows a loss. Something specific to Microsoft is weighing on it relative to the group.
Options positioning confirms that wariness, and has done so all week. The put/call ratio closed Tuesday at 0.45, running 2.6 standard deviations above its 20-day mean of 0.36. That is the same extreme reading flagged in the July 22 trader note — it spiked, briefly retreated, and has now re-established itself. The history is clear: the PCR spent the prior three weeks in a tight band around 0.33-0.39, then jumped hard. Demand for downside protection is running well above its recent base. The earnings playbook the market remembers is April's Q3 print, which produced a 5% drop on the day and a further 3.6% loss over five days — two consecutive negative earnings reactions heading into this result.
The borrow market, however, tells a different story from the options tape. Availability is essentially unbounded — the lending pool dwarfs short interest by an enormous margin, with borrowing costs at just 0.35%, still historically cheap despite a sharp-looking 329% week-on-week change that is misleading in absolute terms (it reflects a move from roughly 0.08% to 0.35%, not a structural tightening). Short interest at 1.25% of the free float has edged up about 4% on the week but remains trivially small for a stock of this size. The short score of 29.9 is stable and unremarkable. There is no meaningful short-side pressure here — the caution is expressed through options, not through a coordinated bear campaign in the lending market.
The fundamental case the Street is making is straightforward and very bullish. Thirteen analysts rate the stock Outperform or better. The consensus price target is $555.77 — that is a 41% premium to Tuesday's close. UBS trimmed its target to $480 from $510 on Monday while keeping its Buy rating, the only notable adjustment this week. The rest of the recent analyst flow has been holds and reiterations rather than meaningful revisions. Bulls point to the 90% reported increase in customer cloud spending intentions over the next 18 months and aggressive AI ecosystem positioning. Bears focus on elevated infrastructure costs, intense competition, and the reality that Q3's 18% revenue growth and strong net income still produced a negative stock reaction. The EPS momentum factor scores remain elevated — 93rd percentile over 30 days, 87th over 90 days — which means the Street has been revising estimates upward into the print.
The valuation context adds nuance. The trailing P/E has compressed to 18.5x from around 20.4x a month ago. EV/EBITDA at 10.9x is also lower than where it was 30 days ago. That de-rating has happened while EPS estimates climbed — a combination that implies the multiple contraction is doing the work, not deteriorating fundamentals. BlackRock reported adding 8.3 million shares in its June filing, and State Street added 3.8 million, suggesting the largest passive holders are not reducing exposure.
Tonight's print is therefore less about whether Microsoft is growing and more about whether Azure's AI monetisation can close the gap between what management has been signalling and what the stock has been pricing in.
See the live data behind this article on ORTEX.
Open MSFT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
